Literature DB >> 18440230

Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart.

Christopher F Spurney1, Susan Knoblach, Emidio E Pistilli, Kanneboyina Nagaraju, Gerard R Martin, Eric P Hoffman.   

Abstract

Duchenne muscular dystrophy (DMD; dystrophin-deficiency) causes dilated cardiomyopathy in the second decade of life in affected males. We studied the dystrophin-deficient mouse heart (mdx) using high-frequency echocardiography, histomorphometry, and gene expression profiling. Heart dysfunction was prominent at 9-10months of age and showed significantly increased LV internal diameter (end systole) and decreased posterior wall thickness. This cardiomyopathy was associated with a 30% decrease in shortening fraction. Histologically, there was a 10-fold increase in connective tissue volume (fibrosis). mRNA profiling with RT-PCR validation showed activation of key pro-fibrotic genes, including Nox4 and Lox. The Nox gene family expression differed in mdx heart and skeletal muscle, where Nox2 was specifically induced in skeletal muscle while Nox4 was specifically induced in heart. This is the first report of an altered profibrotic gene expression profile in cardiac tissue of dystrophic mice showing echocardiographic evidence of cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440230      PMCID: PMC2430663          DOI: 10.1016/j.nmd.2008.03.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  54 in total

1.  Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays.

Authors:  L A Taylor; C M Carthy; D Yang; K Saad; D Wong; G Schreiner; L W Stanton; B M McManus
Journal:  Circ Res       Date:  2000-08-18       Impact factor: 17.367

2.  Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice.

Authors:  Akinori Nakamura; Kunihiro Yoshida; Shin'ichi Takeda; Naoko Dohi; Shu-ichi Ikeda
Journal:  FEBS Lett       Date:  2002-06-05       Impact factor: 4.124

3.  The gene expression fingerprint of human heart failure.

Authors:  Fen-Lai Tan; Christine S Moravec; Jianbo Li; Carolyn Apperson-Hansen; Patrick M McCarthy; James B Young; Meredith Bond
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

4.  Comparative study of high-resolution microimaging with 30-MHz scanner for evaluating cardiac function in mice.

Authors:  Kazue Okajima; Yukio Abe; Kohei Fujimoto; Kana Fujikura; Erin E Girard; Tomohiro Asai; Susan H Kwon; Zhezhen Jin; Yasuhiro Nakamura; Minoru Yoshiyama; Shunichi Homma
Journal:  J Am Soc Echocardiogr       Date:  2007-06-25       Impact factor: 5.251

5.  Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.

Authors:  Joni M Mäki; Juha Räsänen; Hilkka Tikkanen; Raija Sormunen; Kaarin Mäkikallio; Kari I Kivirikko; Raija Soininen
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

6.  Impact of anesthesia on cardiac function during echocardiography in mice.

Authors:  David M Roth; James S Swaney; Nancy D Dalton; Elizabeth A Gilpin; John Ross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

7.  Accuracy of echocardiographic estimates of left ventricular mass in mice.

Authors:  K A Collins; C E Korcarz; S G Shroff; J E Bednarz; R C Fentzke; H Lin; J M Leiden; R M Lang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

8.  Heart regeneration in adult MRL mice.

Authors:  J M Leferovich; K Bedelbaeva; S Samulewicz; X M Zhang; D Zwas; E B Lankford; E Heber-Katz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

9.  Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin.

Authors:  L Loufrani; K Matrougui; D Gorny; M Duriez; I Blanc; B I Lévy; D Henrion
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

10.  Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure.

Authors:  Juey-Jen Hwang; Paul D Allen; George C Tseng; Ching-Wan Lam; Lameh Fananapazir; Victor J Dzau; Choong-Chin Liew
Journal:  Physiol Genomics       Date:  2002-07-12       Impact factor: 3.107

View more
  66 in total

1.  Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.

Authors:  Xinping Chen; Eric D Austin; Megha Talati; Joshua P Fessel; Eric H Farber-Eger; Evan L Brittain; Anna R Hemnes; James E Loyd; James West
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

Review 2.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

3.  Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy.

Authors:  Ingrid E C Verhaart; Hans Heemskerk; Tatyana G Karnaoukh; Ingrid G M Kolfschoten; Anne Vroon; Gert-Jan B van Ommen; Judith C T van Deutekom; Annemieke Aartsma-Rus
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

4.  Calcium-binding proteins in skeletal muscles of the mdx mice: potential role in the pathogenesis of Duchenne muscular dystrophy.

Authors:  Adriana Pertille; Candida Luiza Tonizza de Carvalho; Cintia Yuri Matsumura; Humberto Santo Neto; Maria Julia Marques
Journal:  Int J Exp Pathol       Date:  2009-12-03       Impact factor: 1.925

5.  Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.

Authors:  Kitipong Uaesoontrachoon; James L Quinn; Kathleen S Tatem; Jack H Van Der Meulen; Qing Yu; Aditi Phadke; Brittany K Miller; Heather Gordish-Dressman; Ennio Ongini; Daniela Miglietta; Kanneboyina Nagaraju
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

6.  Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy.

Authors:  Alfredo D Guerron; Rashmi Rawat; Arpana Sali; Christopher F Spurney; Emidio Pistilli; Hee-Jae Cha; Gouri S Pandey; Ramkishore Gernapudi; Dwight Francia; Viken Farajian; Diana M Escolar; Laura Bossi; Magali Becker; Patricia Zerr; Sabine de la Porte; Heather Gordish-Dressman; Terence Partridge; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

7.  Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.

Authors:  Kevin J Morine; Lawrence T Bish; Klara Pendrak; Meg M Sleeper; Elisabeth R Barton; H Lee Sweeney
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

8.  Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Maria C Jordan; Tomomi Gotoh; Wayne W Grody; Kenneth P Roos; James G Tidball
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

9.  Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins.

Authors:  Caroline Lewis; Harald Jockusch; Kay Ohlendieck
Journal:  J Biomed Biotechnol       Date:  2010-05-23

10.  Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse.

Authors:  Christopher F Spurney; Hee-Jae Cha; Arpana Sali; Gouri S Pandey; Emidio Pistilli; Alfredo D Guerron; Heather Gordish-Dressman; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.